Results 181 to 190 of about 291,337 (275)

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

open access: yesAnimal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali   +10 more
wiley   +1 more source

Scientific opinion on the extension of uses of quillaia extract (E 999) as a food additive. [PDF]

open access: yesEFSA J
EFSA Panel on Food Additives and Flavourings (FAF)   +22 more
europepmc   +1 more source

Scientific opinion on the presence of DNA in the feed additive consisting of l-isoleucine produced by Corynebacterium glutamicum KCCM 80185 for all animal species (CJ Europe GmbH). [PDF]

open access: yesEFSA J, 2023
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +21 more
europepmc   +1 more source

Residency Research Quality Outweighs Quantity in Predicting Sports Medicine Fellowship Placement

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To determine whether academic productivity during residency correlates with the type of orthopaedic sports medicine fellowship program attended. Methods All orthopaedic sports medicine fellowship programs accredited by the Accreditation Council for Graduate Medical Education were identified by cross‐referencing databases from the Arthroscopy ...
Carolina Gomez   +4 more
wiley   +1 more source

Scientific opinion on flavouring group evaluation 414 (FGE.414): 2-hydroxy-4-methoxybenzaldehyde. [PDF]

open access: yesEFSA J, 2021
EFSA Panel on Food Additives and Flavourings (FAF)   +24 more
europepmc   +1 more source

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

open access: yesArthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro   +17 more
wiley   +1 more source

Update of the scientific opinion on tetrabromobisphenol A (TBBPA) and its derivatives in food. [PDF]

open access: yesEFSA J
EFSA Panel on Contaminants in the Food Chain (CONTAM)   +25 more
europepmc   +1 more source

Body donor programs in Australia and New Zealand: Current status and future opportunities

open access: yesAnatomical Sciences Education, Volume 18, Issue 3, Page 301-328, March 2025.
Abstract Body donation is critical to anatomy study in Australia and New Zealand. Annually, more than 10,000 students, anatomists, researchers, and clinicians access tissue donated by local consented donors through university‐based body donation programs. However, little research has been published about their operations.
Rebekah A. Jenkin, Kevin A. Keay
wiley   +1 more source

Home - About - Disclaimer - Privacy